| 2011 | Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib.
| EXPERIMENTAL AND THERAPEUTIC MEDICINE |
| 2011 | Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity | ONCOLOGY |
| 2011 | Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer
| CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2011 | Treatment of recurrent hepatocellular carcinoma after liver transplantation | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY |
| 2011 | CD44-SLC1A2 gene fusions in gastric cancer.
| SCIENCE TRANSLATIONAL MEDICINE |
| 2011 | Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles. | ONCOLOGY |
| 2011 | A prognostic model to predict clinical outcome in gastric cancer patients with bone metastasis | ONCOLOGY |
| 2011 | Predictive values of 5-fluorouracil pathway genes for S-1 treatment in patients with advanced gastric cancer | ANTI-CANCER DRUGS |
| 2011 | A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy
| CANCER |
| 2011 | Economic and patient-reported outcomes of outpatient home-based versus inpatient hospital-based chemotherapy for patients with colorectal cancer | SUPPORTIVE CARE IN CANCER |
| 2011 | Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases | INVESTIGATIVE RADIOLOGY |
| 2011 | Prevalence and associated factors of psychological distress among Korean cancer patients | GENERAL HOSPITAL PSYCHIATRY |
| 2011 | Genome-wide molecular characterization of mucinous colorectal adenocarcinoma using cDNA microarray analysis. | ONCOLOGY REPORTS |
| 2011 | Identification of genes associated with chemosensitivity to SAHA/taxane combination treatment in taxane-resistant breast cancer cells | BREAST CANCER RESEARCH AND TREATMENT |
| 2011 | Brain metastases from colorectal carcinoma: prognostic factors and outcome | JOURNAL OF NEURO-ONCOLOGY |
| 2010 | Kidney Cancer Working Group report.
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2010 | Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites
| CANCER RESEARCH AND TREATMENT |
| 2010 | Novel sunitinib strategy in metastatic renal cell carcinoma on hemodialysis: intermittent dose of sunitinib after hemodialysis.
| CANCER RESEARCH AND TREATMENT |
| 2010 | The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up | ANNALS OF SURGICAL ONCOLOGY |
| 2010 | Green tea consumption and stomach cancer risk: a meta-analysis
| EPIDEMIOLOGY AND HEALTH |
| 2010 | Wernicke's encephalopathy in advanced gastric cancer
| CANCER RESEARCH AND TREATMENT |
| 2010 | Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma | INTERNATIONAL JOURNAL OF HYPERTHERMIA |
| 2010 | Identification of novel gastric cancer-associated CNVs by integrated analysis of microarray | JOURNAL OF SURGICAL ONCOLOGY |
| 2010 | Chemokine growth-regulated oncogene 1 as a putative biomarker for gastric cancer progression | CANCER SCIENCE |
| 2010 | Molecular characterization of alternative SET-NUP214 fusion transcripts in a case of acute undifferentiated leukemia. | CANCER GENETICS AND CYTOGENETICS |
| 2010 | A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer | INVESTIGATIONAL NEW DRUGS |
| 2010 | Outcomes of multiple salvage chemotherapy for advanced gastric cancer: implications for clinical practice and trial design | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2010 | Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2010 | Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer | RADIOTHERAPY AND ONCOLOGY |
| 2010 | The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2010 | Identification of genes related to a synergistic effect of taxane and suberoylanilide hydroxamic acid combination treatment in gastric cancer cells | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2010 | A phase II study of a combined biweekly irinotecan and monthly cisplatin treatment for metastatic or recurrent gastric cancer. | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
| 2010 | Association of the ABCB1 3435C>T polymorphism and treatment outcomes in advanced gastric cancer patients treated with paclitaxel-based chemotherapy. | ONCOLOGY REPORTS |
| 2010 | Two dosages of oral fluoropyrimidine S-1 of 35 and 40 mg/m2 bid: comparison of the pharmacokinetic profiles in Korean patients with advanced gastric cancer
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2010 | Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients | CANCER LETTERS |
| 2009 | Benefits of recurrent colonic stent insertion in a patient with advanced gastric cancer with carcinomatosis causing colonic obstruction
| YONSEI MEDICAL JOURNAL |
| 2009 | Prognostic index reflecting genetic alteration related to disease-free time for gastric cancer patient | ONCOLOGY REPORTS |
| 2009 | Changes of telomerase activity by alternative splicing of full-length and beta variants of hTERT in breast cancer patients. | ONCOLOGY RESEARCH |
| 2009 | Docetaxel versus paclitaxel combined with 5-FU and leucovorin in advanced gastric cancer: combined analysis of two phase II trials.
| CANCER RESEARCH AND TREATMENT |
| 2009 | A phase II feasibility study of weekly paclitaxel in heavily pretreated advanced gastric cancer patients with poor performance status | ONCOLOGY |
| 2009 | Increments of alpha-dystroglycan expression in liver metastasis correlate with poor survival in gastric cancer | JOURNAL OF SURGICAL ONCOLOGY |
| 2009 | Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma
| ANNALS OF ONCOLOGY |
| 2009 | Clinical value of ezrin expression in primary osteosarcoma
| CANCER RESEARCH AND TREATMENT |
| 2009 | Prognosis of pN3 stage gastric cancer
| CANCER RESEARCH AND TREATMENT |
| 2009 | Treatment outcomes of sunitinib treatment in advanced renal cell carcinoma patients: a single cancer center experience in Korea
| CANCER RESEARCH AND TREATMENT |
| 2009 | Oncogenic pathway combinations predict clinical prognosis in gastric cancer
| PLOS GENETICS |
| 2009 | Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies. | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2009 | Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer. | ONCOGENE |
| 2009 | DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers
| BRITISH JOURNAL OF CANCER |
| 2009 | Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer.
| CANCER |
http://orcid.org/0000-0002-2512-4531
(7006023235)
